Autologous blood stem cell transplantation for acute myeloblastic leukemia in first complete remission. Intensification therapy before transplantation does not prolong disease-free survival.

Autores de IIS La Fe

• 

  Javier De La Rubia Comos

  Autor

• Guillermo Sanz Santillana

  Autor

• Guillermo Martin Aragones

  Autor

• Jesus Antonio Martinez Dominguez

  Autor

• José Vicente Cervera Zamora

  Autor

• Pilar Solves Alcaina

  Autor

• Mario Arnao Herraiz

  Autor

• Isidro Jarque Ramos

  Autor

• Amparo Sempere Talens

  Autor

• Miguel Ángel Sanz Alonso

  Autor

Participantes ajenos a IIS La Fe

• Jiménez C
• Vicente A

Abstract

To compare the clinical results of two consecutive therapeutic protocols including autologous blood stem cell transplantation (ABSCT) for patients with de novo acute myeloblastic leukemia (AML) in first complete remission (CR1).